Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

How to protect liver graft with nitric oxide.

Ben Abdennebi H, Zaoualí MA, Alfany-Fernandez I, Tabka D, Roselló-Catafau J.

World J Gastroenterol. 2011 Jun 28;17(24):2879-89. doi: 10.3748/wjg.v17.i24.2879.

2.

Retinol-binding protein 4 and peroxisome proliferator-activated receptor-γ in steatotic liver transplantation.

Casillas-Ramírez A, Alfany-Fernández I, Massip-Salcedo M, Juan ME, Planas JM, Serafín A, Pallàs M, Rimola A, Rodés J, Peralta C.

J Pharmacol Exp Ther. 2011 Jul;338(1):143-53. doi: 10.1124/jpet.110.177691. Epub 2011 Apr 12.

PMID:
21487070
3.

Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion.

Ben Mosbah I, Alfany-Fernández I, Martel C, Zaouali MA, Bintanel-Morcillo M, Rimola A, Rodés J, Brenner C, Roselló-Catafau J, Peralta C.

Cell Death Dis. 2010 Jul 8;1:e52. doi: 10.1038/cddis.2010.29.

4.

How Institut Georges Lopez preservation solution protects nonsteatotic and steatotic livers against ischemia-reperfusion injury.

Zaouali MA, Ben Abdennebi H, Padrissa-Altés S, Alfany-Fernandez I, Rimola A, Roselló-Catafau J.

Transplant Proc. 2011 Jan-Feb;43(1):77-9. doi: 10.1016/j.transproceed.2010.12.026. Review.

PMID:
21335159
5.

Improved rat steatotic and nonsteatotic liver preservation by the addition of epidermal growth factor and insulin-like growth factor-I to University of Wisconsin solution.

Zaouali MA, Padrissa-Altés S, Ben Mosbah I, Alfany-Fernandez I, Massip-Salcedo M, Casillas-Ramirez A, Bintanel-Morcillo M, Boillot O, Serafin A, Rimola A, Rodés J, Roselló-Catafau J, Peralta C.

Liver Transpl. 2010 Sep;16(9):1098-111. doi: 10.1002/lt.22126.

6.

Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.

Ben Mosbah I, Roselló-Catafau J, Alfany-Fernandez I, Rimola A, Parellada PP, Mitjavila MT, Lojek A, Ben Abdennebi H, Boillot O, Rodés J, Peralta C.

Liver Transpl. 2010 Feb;16(2):163-71. doi: 10.1002/lt.21968.

7.

Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury.

Casillas-Ramírez A, Zaouali A, Padrissa-Altés S, Ben Mosbah I, Pertosa A, Alfany-Fernández I, Bintanel-Morcillo M, Xaus C, Rimola A, Rodés J, Roselló-Catafau J, Peralta C.

Endocrinology. 2009 Jul;150(7):3153-61. doi: 10.1210/en.2008-1458. Epub 2009 Mar 12.

8.

Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts.

Alfany-Fernandez I, Casillas-Ramirez A, Bintanel-Morcillo M, Brosnihan KB, Ferrario CM, Serafin A, Rimola A, Rodés J, Roselló-Catafau J, Peralta C.

Am J Transplant. 2009 Mar;9(3):439-51. doi: 10.1111/j.1600-6143.2008.02521.x. Epub 2008 Feb 3.

9.

Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?

Ramalho FS, Alfany-Fernandez I, Casillas-Ramirez A, Massip-Salcedo M, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C.

J Pharmacol Exp Ther. 2009 Apr;329(1):130-40. doi: 10.1124/jpet.108.147835. Epub 2008 Dec 30.

PMID:
19116369

Supplemental Content

Loading ...
Support Center